The United States launched an investigation into Germany's pharmaceutical pricing policies on Thursday, potentially opening the door to new tariffs. According to France 24, Washington is examining whether Germany's pricing practices unfairly underpay for innovative medicines and burden US commerce. The investigation operates under Section three-oh-one trade authorities.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton